Vifor, Angion organ damage drug fails phase 3 kidney transplant studyVifor Pharma and partner Angion Biomedica have suffered another setback with their drug to prevent organ damage, this Share XVifor, Angion organ damage drug fails phase 3 kidney transplant studyhttps://pharmaphorum.com/news/vifor-angion-organ-damage-drug-fails-phase-3-kidney-transplant-study/
Lilly files Alzheimer’s drug donanemab as Cortexyme rival fails trialEli Lilly has followed through on its plan to file for approval of its Alzheimer’s disease candidate donanemab, Share XLilly files Alzheimer’s drug donanemab as Cortexyme rival fails trialhttps://pharmaphorum.com/news/lilly-files-alzheimers-drug-donanemab-as-cortexyme-rival-fails-trial/
Seagen’s breast cancer drug Tukysa turned down by NICENICE has decided not to recommend Seagen’s orally-active HER2 inhibitor Tukysa for advanced breast cancer in draft guidance, Share XSeagen’s breast cancer drug Tukysa turned down by NICEhttps://pharmaphorum.com/news/seagens-breast-cancer-drug-tukysa-turned-down-by-nice/
Health Innovators: Healios’ Richard AndrewsIn the latest Health Innovators video chat, pharmaphorum’s founder, Dr Paul Tunnah, chats with the founder and CEO Share XHealth Innovators: Healios’ Richard Andrewshttps://pharmaphorum.com/digital/health-innovators-healios-richard-andrews/
How are the European pharma and biotech sectors addressing strategic communications?Stakeholder expectations are high and, with all eyes on healthcare at the moment, it is essential for companies Share XHow are the European pharma and biotech sectors addressing strategic communications?https://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/european-pharma-biotech-strategic-communications/
What HCPs think about medical tweetorialsTwitter has been used by health professionals for over a decade to share medical knowledge and education. Until Share XWhat HCPs think about medical tweetorialshttps://pharmaphorum.com/digital/medical-education-hcps-medical-tweetorials/
How are the European pharma and biotech sectors addressing strategic communications?Stakeholder expectations are high and, with all eyes on healthcare at the moment, it is essential for companies Share XHow are the European pharma and biotech sectors addressing strategic communications?https://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/european-pharma-biotech-strategic-communications/
BMS’ Catherine Owen: Hybrid communication is here to stayThe company’s senior vice president for major markets (Europe, Canada and Japan) talks about the continued evolution of Share XBMS’ Catherine Owen: Hybrid communication is here to stayhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/bristol-myers-squibb-bms-catherine-owen/
A Life in a Day by The MethodPatient centricity has become a key aspiration for the pharma industry over the last several years, but getting Share XA Life in a Day by The Methodhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/the-method-patient-empathy-engagement/
The power of R&D collaborations to improve outcomes in rare diseases Share XThe power of R&D collaborations to improve outcomes in rare diseaseshttps://pharmaphorum.com/webinars/pharma-research-outcomes-rare-diseases/
Using AI to make a big impact for emerging and mid-sized biopharma companies Share XUsing AI to make a big impact for emerging and mid-sized biopharma companieshttps://pharmaphorum.com/webinars/using-ai-to-make-a-big-impact-for-emerging-and-mid-sized-biopharma-companies/
The digital transformation of pharma’s physician engagement strategies Share XThe digital transformation of pharma’s physician engagement strategieshttps://pharmaphorum.com/webinars/digital-transformation-pharma-engagement-p360/
Transform patient experience with intelligent hyper-personalisationSince 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and Share XTransform patient experience with intelligent hyper-personalisationhttps://pharmaphorum.com/whitepapers/patient-experience-personalisation-indegene/
4 ways emerging pharma companies can harness marketing contentRapid creation of compliant marketing content is increasingly important and there are ways emerging pharma companies can stay Share X4 ways emerging pharma companies can harness marketing contenthttps://pharmaphorum.com/whitepapers/emerging-pharma-marketing-content-veeva/
How pharma can help the post-COVID recovery of European cancer careThe new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and Share XHow pharma can help the post-COVID recovery of European cancer carehttps://pharmaphorum.com/whitepapers/pharma-covid-recovery-cancer-care/
Health Innovators: Healios’ Richard Andrews Share XHealth Innovators: Healios’ Richard Andrewshttps://pharmaphorum.com/digital/health-innovators-healios-richard-andrews/
BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast Share XBMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/bms-catherine-owen-pharma-commercialisation/
Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast Share XNovartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/novartis-amit-nastik-pharma-supply-chain/
Future focus: 3 tools for launching fast in the face of uncertainty Share XFuture focus: 3 tools for launching fast in the face of uncertaintyhttps://pharmaphorum.com/partner-content/future-focus-3-tools-for-launching-fast-in-the-face-of-uncertainty/
Are You Speaking a Patient’s Language?: 5 Terms Used By Patients Share XAre You Speaking a Patient’s Language?: 5 Terms Used By Patientshttps://pharmaphorum.com/partner-content/are-you-speaking-a-patients-language-5-terms-used-by-patients/
Identifying And Engaging Digital Opinion Leaders Share XIdentifying And Engaging Digital Opinion Leadershttps://pharmaphorum.com/partner-content/identifying-and-engaging-digital-opinion-leaders/
Release of International Book: DTx: An Opportunity for Italy and Beyond Share XRelease of International Book: DTx: An Opportunity for Italy and Beyondhttps://pharmaphorum.com/partner-content/release-of-international-book-dtx-an-opportunity-for-italy-and-beyond/
AXON appoints Colette Balaam as its new US Managing Partner Share XAXON appoints Colette Balaam as its new US Managing Partnerhttps://pharmaphorum.com/partner-content/axon-appoints-colette-balaam-as-its-new-us-managing-partner/
Prescient Healthcare Group to Partner with Bridgepoint Development Capital Share XPrescient Healthcare Group to Partner with Bridgepoint Development Capitalhttps://pharmaphorum.com/partner-content/prescient-healthcare-group-to-partner-with-bridgepoint-development-capital/
